http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_963e25894b5372e9aa72fbce3663abd0
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Lindén |
| name | Daniel Lindén |
| given-name | Daniel |
| organization-name | Department of Physiology, Göteborg University, S-405 30 Goteborg, Sweden Cardiovascular & Metabolic Diseases iMed and ‡Global Medicines Development, AstraZeneca Gothenburg, 431 83 Mölndal, Sweden Department of Physiology, Göteborg University, S-405 30 Göteborg; and Bioscience Metabolism, Research and Early Development Cardiovascular, Renal and Metabolism (CVRM) BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden; Division of Endocrinology Department of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Departments of Physiology, Department of Physiology, Göteborg University, 405 30 Goteborg; and Division of Endocrinology, Department of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden; Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit, AstraZeneca, Gothenburg, Sweden AstraZeneca R&D Mölndal Sweden; Wallenberg Laboratory for Cardiovascular ResearchGöteborg University Sweden Research and Early Development Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden; Division of Endocrinology Department of Neuroscience and Physiology Sahlgrenska Academy University of Gothenburg Gothenburg Sweden Cardiovascular and Metabolic Diseases Innovative Medicines and Early Development Biotech Unit, AstraZeneca Gothenburg, Sweden; Cardiovascular & Metabolic Diseases innovative Medicines (CVMD iMed) AstraZeneca Mölndal Sweden |
Incoming Links
Total number of triples: 51.